Pay For Performance Drug Pricing
Recent improvements in data infrastructure support a renewed focus on structuring and executing more elaborate types of pay-for-performance agreements. However, historical experiences have shown that, in practice, pay for performance schemes can be difficult and costly to administer along with difficulties in monitoring patient outcomes and in clawing back rebates. To optimally operationalize such pay for performance schemes, and make the best use of the data, the infrastructure to adequately track patients and enforce rebates must be in place. View the webinar recording to learn more.